查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1370315

流式细胞仪市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Flow Cytometry Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

抽象的

市场概况：

2022年全球流式细胞仪市场规模达54亿美元。展望未来，IMARC集团预计到2028年市场规模将达到86亿美元，2023-2028年复合年增长率（CAGR）为8.1%。个人化医疗产品的广泛采用、生命科学和生物技术研究活动的扩大以及对学术和研究机构的资助不断增加是推动市场的一些主要因素。

流式细胞仪是一种可以对异质群体中的单一细胞进行详细多参数分析的技术。该技术使用光来检测和测量细胞或颗粒群的物理和化学特性。每个颗粒悬浮在流体流中并通过电子检测装置。将一束光射到流上，光散射是粒子及其特性的特征。这些模式的强度可用于导出有关每个细胞的物理和化学结构的各种类型的资料。这些资讯在诊断和生物医学研究等广泛应用中都很有价值。它可以每秒快速分析数千个粒子，并同时收集有关单一细胞的多个参数的资料。因此，它是细胞生物学和医学的重要工具。

生命科学和生物技术研究活动的扩展主要推动全球市场。它是细胞生物学、免疫学和肿瘤学研究的重要工具。它广泛用于细胞週期和增殖、凋亡和其他细胞功能的研究。这些研究领域（尤其是发展中国家）的投资不断增加，影响了对这些仪器、试剂和软体的需求。此外，这些方法在疾病检测和监测方面的精确度和效率使其成为个人化医疗的理想选择。随着这种医疗模式的采用率不断上升，它正在显着推动市场的成长。除此之外，学术和研究机构，特别是从事细胞研究的学术和研究机构的资金不断增加，一直是市场的重要推动力。这些资金有助于购买先进的细胞计数技术和新应用的开发，并推动整体市场的成长。此外，人们越来越意识到早期诊断和治疗的好处，加上中产阶级人口的不断增长，正在创造积极的市场前景。

流式细胞仪市场趋势/驱动因素：

慢性病盛行率增加

癌症、爱滋病毒/爱滋病和其他免疫系统相关疾病等慢性病发病率的上升极大地推动了对流式细胞仪的需求。除此之外，流式细胞仪在几种血液恶性肿瘤的诊断和预后中不可或缺，并且越来越多地用于监测疾病进展和治疗反应。随着全球人口老化和此类疾病的盛行率增加，对快速、准确的诊断和监测工具的需求也在增加。因此，医疗保健产业不断努力提供有效的治疗和改善患者的生活质量，成为流式细胞仪市场的重要驱动力。

增加临床试验和药物发现的采用

该方法在临床试验和药物发现中的广泛采用是一个重要的市场驱动力。此外，流式细胞仪能够提供有关单一细胞和细胞群的详细信息，使其成为评估药物效果和识别潜在治疗靶点的理想选择。除此之外，製药公司越来越依赖这些方法进行临床前测试和临床试验，以评估新药的安全性和有效性。因此，它对市场产生正面影响。随着製药业的不断扩大和新药候选数量的不断增加，该领域对流式细胞仪的需求大幅加速，推动了市场的整体成长。

持续的技术进步

流式细胞仪产业的主要市场驱动力之一是该领域的持续技术进步。高通量流式细胞仪的出现、提供更好资料分析的软体解决方案的进步以及特定探针和试剂的开发显着提高了流式细胞仪的功效。此外，紧凑、用户友好且价格实惠的系统的引入导致了该技术的民主化，将其用途从研究实验室扩展到临床环境，甚至床边诊断。多色检测和试剂也增加，可以同时检测许多参数，进一步增强了能力。这些进步不仅提供了更有效率、更可靠的结果，而且扩大了潜在应用范围，从而促进了市场的成长。

流式细胞仪产业细分：

IMARC Group 提供了全球流式细胞仪市场报告各细分市场主要趋势的分析，以及 2023-2028 年全球、区域和国家层面的预测。我们的报告根据产品和服务、技术、应用和最终用户对市场进行了分类。

按产品和服务细分：

仪器

试剂及耗材

配件

软体

服务

仪器仪表主导市场

该报告根据产品和服务对市场进行了详细的细分和分析。这包括仪器、试剂和消耗品、配件、软体和服务。报告称，仪器仪表占最大部分。

在该行业中，仪器和服务的市场驱动因素是多方面的。随着仪器变得更加精确、用户友好且价格实惠，它们促进了应用范围的扩大，从而推动了需求。此外，便携式和台式流式细胞仪的发展使该技术更容易获得，从而促进了这些仪器的销售。由于流式细胞仪在各个领域的使用不断增加，与流式细胞仪相关的服务（例如维护、培训和资料分析）的需求也不断增加。方法资料的复杂性需要专门的软体和熟练的专业人员进行分析，因此这些服务至关重要。随着越来越多的企业和研究机构采用流式细胞仪，他们经常寻求这些服务以确保有效的操作和准确的​​结果，从而进一步推动这些服务的市场。

按技术划分：

基于细胞的流式细胞仪

基于珠的流式细胞仪

基于细胞的流式细胞仪主导市场

报告还提供了基于该技术的详细市场细分和分析。这包括基于细胞的流式细胞仪和基于珠的流式细胞术。根据该报告，基于细胞的流式细胞仪代表了最大的部分。

该行业中基于细胞的技术市场是由癌症等疾病发病率不断增加所推动的，在癌症的诊断和监测中发挥关键作用。该技术提供了有关细胞特征和行为的宝贵信息，对于了解疾病进展和治疗反应至关重要。此外，包括干细胞研究和细胞治疗在内的细胞研究的进步，对市场成长做出了重大贡献。这些领域需要深入的细胞分析，而流式细胞仪是满足这些需求的关键工具。此外，对个人化医疗日益增长的兴趣是另一个驱动因素，个人化医疗需要细胞层面的精确资讯来制定个人化治疗策略。此外，基因组学和蛋白​​质组学中单细胞分析的兴起正在增加对基于细胞的流式细胞仪的需求，因为它能够分析群体中的单一细胞。

按应用划分：

肿瘤学

药物发现

疾病诊断

干细胞治疗

器官移植

血液学

其他的

肿瘤学占市场主导地位

该报告根据应用程式提供了详细的市场细分和分析。这包括肿瘤学、药物发现、疾病诊断、干细胞治疗、器官移植、血液学等。根据该报告，肿瘤学占最大的部分。

肿瘤学领域的市场很大程度上是由全球癌症发生率上升以及该方法在癌症研究和患者管理中不可或缺的作用所推动的。流式细胞仪可对细胞群进行快速、详细的分析，对于诊断各种形式的癌症，特别是血液恶性肿瘤至关重要。它也广泛用于监测疾病进展和治疗反应，从而有助于癌症管理的决策过程。同时，肿瘤学中个人化医疗的不断采用，需要高解析度细胞分析来制定量身定制的治疗策略，进一步推动了对流式细胞仪的需求。此外，流式细胞仪技术的进步，例如多色流式细胞仪的发展，显着增强了其在癌症研究方面的能力。

按最终用户划分：

医院和诊所

学术及研究机构

製药和生物技术公司

其他的

医院和诊所主导市场

报告还提供了基于最终用户的详细市场细分和分析。这包括医院和诊所、学术和研究机构、製药和生物技术公司等。根据该报告，以细胞为基础的医院和诊所代表了最大的部分。

医院和诊所内的市场是由需要流式细胞仪进行诊断和监测的疾病（例如癌症和免疫性疾病）日益流行所推动的。随着这些疾病的患者负荷增加，这些医疗保健环境中对快速、准确的诊断工具的需求也随之增加。此外，技术进步带来了更紧凑和用户友好的流式细胞仪，使医院和诊所更容易采用该技术。个人化医疗的兴起也促进了流式细胞仪在这些环境中的使用，因为它提供了个人化治疗策略所需的详细细胞分析。此外，随着这种方法因其提供快速、全面结果的能力而得到越来越多的认可，保险公司越来越多地涵盖基于流式细胞仪的测试，进一步促进其在医院和诊所的采用。

按地区划分：

北美洲

美国

加拿大

亚太地区

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美表现出明显的主导地位，占据最大的流式细胞仪市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美占据最大的市场份额。

北美流式细胞仪产业的成长是由完善的医疗基础设施和强大的研究环境所推动的，这两者都促进了先进技术的采用和开发。除此之外，癌症等慢性疾病的高发生率也促进了市场的成长，这种方法在诊断和监测中发挥着至关重要的作用。此外，该地区领先公司的存在支持创新技术和应用的开发。此外，对研发的大量投资，包括广泛使用流式细胞仪的生物医学研究、临床试验和药物发现过程，进一步推动了市场成长。该地区对个人化医疗的兴趣日益浓厚，需要流式细胞仪提供详细的细胞分析，这也促进了市场需求。

竞争格局：

由于对先进流式细胞仪技术的研发投资不断增加，全球流式细胞仪市场正经历显着成长。这包括开发新仪器、试剂、软体和方法。这些进步旨在增强流式细胞仪的功能，使其更加精确、高效和用户友好。同时，与其他企业、研究机构和医疗保健提供者的策略合作伙伴关係的不断增加也极大地支持了市场。这些合作通常旨在推动研究、开发新应用并扩大流式细胞仪技术的范围。除此之外，製造商还推出教育和培训服务，例如研讨会、网路研讨会或线上教程，以帮助用户在工作中充分利用流式细胞仪的潜力。因此，它对市场有很大的支撑。此外，主要参与者正在提供强大的客户服务和技术支持，这正在创造积极的市场前景。

该报告对全球流式细胞仪市场的竞争格局进行了全面分析。也提供了所有主要公司的详细资料。市场上的一些主要参与者包括：

安捷伦科技公司

Apogee Flow 系统有限公司

BD（贝克顿迪金森公司）

贝克曼库尔特公司（丹纳赫公司）

Bio-RAD 实验室公司

恩佐生命科学公司

鲁米奈克斯公司

默克公司

索尼生技公司

希森美康帕泰克有限公司

赛默飞世尔科技公司

最近的发展：

2023 年 2 月，安捷伦科技公司宣布推出新的 NovoExpress 软体，该软体为 NovoCyte 流式细胞仪设备带来了整合合规性工具。

2023 年6 月，BD（Becton、Dickinson and Company）宣布在全球商业推出一款新型自动化设备，该设备可使用流式细胞仪清洁临床诊断样品，提供完整的「无人值守」工作流程解决方案，旨在提高细胞诊断的标准化和可重复性。

2021 年 6 月，Bio-RAD Laboratories Inc. 发布了三种用于流式细胞仪的 StarBright 染料。 StarBright Violet 570、670 和 710 染料适用于多色流式细胞仪面板，因为它们具有增强的亮度以及准确的激发和发射光谱。

本报告回答的关键问题

  • 2022年全球流式细胞仪市场规模是多少
  • 2023-2028年全球流式细胞仪市场的预期成长率是多少
  • 推动全球流式细胞仪市场的关键因素是什么
  • COVID-19 对全球流式细胞仪市场有何影响
  • 基于产品和服务的全球流式细胞仪市场的细分是什么
  • 基于该技术的全球流式细胞仪市场的细分情况如何
  • 基于应用的全球流式细胞仪市场区隔是怎样的
  • 基于最终用户的全球流式细胞仪市场的细分是什么
  • 全球流式细胞仪市场的重点区域有哪些
  • 10. 全球流式细胞仪市场的主要参与者/公司有哪些？

本报告回答的关键问题

  • 2022年全球流式细胞仪市场规模有多大？
  • 2023-2028年全球流式细胞仪市场的预期成长率是多少？
  • 推动全球流式细胞仪市场的关键因素是什么？
  • COVID-19 对全球流式细胞仪市场有何影响？
  • 根据产品和服务，全球流式细胞仪市场的细分情况如何？
  • 基于该技术的全球流式细胞仪市场的细分情况如何？
  • 基于应用的全球流式细胞仪市场的细分情况如何？
  • 根据最终用户，全球流式细胞仪市场的细分情况如何？
  • 全球流式细胞仪市场的关键区域有哪些？
  • 全球流式细胞仪市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球流式细胞仪市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按产品和服务分類的市场

  • 仪器
    • 市场走向
    • 市场预测
  • 试剂及耗材
    • 市场走向
    • 市场预测
  • 配件
    • 市场走向
    • 市场预测
  • 软体
    • 市场走向
    • 市场预测
  • 服务
    • 市场走向
    • 市场预测

第 7 章：依科技分類的市场

  • 基于细胞的流式细胞仪
    • 市场走向
    • 市场预测
  • 基于珠的流式细胞仪
    • 市场走向
    • 市场预测

第 8 章：按应用分類的市场区隔

  • 肿瘤学
    • 市场走向
    • 市场预测
  • 药物发现
    • 市场走向
    • 市场预测
  • 疾病诊断
    • 市场走向
    • 市场预测
  • 干细胞治疗
    • 市场走向
    • 市场预测
  • 器官移植
    • 市场走向
    • 市场预测
  • 血液学
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：最终用户的市场区隔

  • 医院和诊所
    • 市场走向
    • 市场预测
  • 学术及研究机构
    • 市场走向
    • 市场预测
  • 製药和生物技术公司
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太地区
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies Inc.
    • Apogee Flow Systems Ltd.
    • BD (Becton, Dickinson and Company)
    • Beckman Coulter Inc. (Danaher Corporation)
    • Bio-RAD Laboratories Inc.
    • Enzo Life Sciences Inc.
    • Luminex Corporation
    • Merck KGaA
    • Sony Biotechnology Inc.
    • Sysmex Partec GmbH
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A2272

Abstract

Market Overview:

The global flow cytometry market size reached US$ 5.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.6 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028. The widespread product adoption in personalized medicine, the expansion of research activities in life sciences and biotechnology, and the accelerating funding for academic and research institutes are some of the major factors propelling the market.

Flow cytometry is a technology that allows detailed multi-parameter analysis of individual cells within a heterogeneous population. This technique uses light to detect and measure physical and chemical properties of a population of cells or particles. Each particle is suspended in a stream of fluid and passed through an electronic detection apparatus. A beam of light is directed onto the stream, and the light scatter is characteristic of the particles and their properties. The intensity of these patterns can be used to derive various types of data about the physical and chemical structure of each cell. This information is valuable in a wide range of applications, including diagnostics and biomedical research. It can quickly analyze thousands of particles per second and concurrently gather data about multiple parameters of a single cell. Therefore, it is an essential tool in cell biology and medicine.

The expansion of research activities in life sciences and biotechnology majorly drives the global market. It is a crucial tool in cell biology, immunology, and oncology research. It is extensively used in the study of cell cycle and proliferation, apoptosis, and other cellular functions. The rising investments in these research areas, especially in developing countries, have influenced the demand for these instruments, reagents, and software. In addition, the precision and efficiency of these method in the detection and monitoring of diseases make it ideal for personalized medicine. As this medical model continues to rise in adoption, it is significantly driving the growth of the market. Apart from this, the accelerating funding for academic and research institutes, particularly those engaged in cell-based research, has been a considerable driver for the market. These funds facilitate the purchase of advanced cytometry technologies and the development of new applications, driving the overall market growth. Moreover, the accelerating awareness about the benefits of early diagnosis and therapeutics, coupled with a growing middle-class population is creating a positive market outlook.

Flow Cytometry Market Trends/Drivers:

Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases such as cancer, HIV/AIDS, and other immune system-related diseases has substantially driven the demand for flow cytometry. Along with this, flow cytometry is indispensable in the diagnosis and prognosis of several hematological malignancies and is increasingly being used in monitoring disease progression and treatment response. As the global population ages and the prevalence of such diseases increases, the need for fast, accurate diagnostic and monitoring tools also grows. Consequently, the healthcare sector's ongoing efforts to provide effective treatments and improve patients' quality of life act as a significant driving force for the flow cytometry market.

Increased Adoption in Clinical Trials and Drug Discovery

The widespread adoption of the method in clinical trials and drug discovery is a significant market driver. In addition, flow cytometry's ability to provide detailed information about individual cells and cellular populations makes it ideal for evaluating drug effects and identifying potential therapeutic targets. Apart from this, pharmaceutical companies are increasingly relying on these methods for preclinical testing and clinical trials to assess the safety and efficacy of new drugs. Therefore, it is positively influencing the market. With the expanding pharmaceutical industry and escalating number of new drug candidates, the demand for flow cytometry in this domain is accelerating substantially, driving the overall growth of the market.

Continuous Technological Advancements

One of the primary market drivers for the flow cytometry industry is the continued technological advancements in this field. The emergence of high-throughput flow cytometry, advancement in software solutions that offer better data analysis, and development of specific probes and reagents have significantly improved the efficacy of flow cytometry. Additionally, the introduction of compact, user-friendly, and affordable systems has led to the democratization of this technology, expanding its use from research labs to clinical settings and even point-of-care diagnostics. There has also been a rise in multicolor assays and reagents which allow simultaneous detection of many parameters, further enhancing the capabilities. These advancements not only provide more efficient and reliable results but also widen the range of potential applications, thereby contributing to the growth of the market.

Flow Cytometry Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global flow cytometry market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product and service, technology, application and end-user.

Breakup by Product and Service:

Instruments

Reagents and Consumables

Accessories

Software

Services

Instruments dominate the market

The report has provided a detailed breakup and analysis of the market based on the product and service. This includes instruments, reagents and consumables, accessories, software, and services. According to the report, instruments represented the largest segment.

In the industry, market drivers for instruments and services are multifaceted. As instruments become more precise, user-friendly, and affordable, they facilitate an expanded range of applications, thus driving demand. In addition, the development of portable and benchtop flow cytometers has made the technology more accessible, boosting the sales of these instruments. Services related to flow cytometry, such as maintenance, training, and data analysis, also experience increased demand driven by the growing usage of this method in various sectors. The complexity of the method data requires specialized software and skilled professionals for analysis, making these services critical. As more businesses and research institutions adopt flow cytometry, they often seek out these services to ensure effective operation and accurate results, further propelling the market for these services.

Breakup by Technology:

Cell-Based Flow Cytometry

Bead-Based Flow Cytometry

Cell-based flow cytometry dominates the market

A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes cell-based flow cytometry and bead-based flow cytometry. According to the report, cell-based flow cytometry represented the largest segment.

The market for cell-based technology in the industry is driven by the increasing incidence of diseases such as cancer, where it plays a critical role in diagnosis and monitoring. This technology provides valuable information about cellular characteristics and behavior, making it crucial for understanding disease progression and treatment response. In addition, advancements in cell-based research, including stem cell research and cell therapeutics, contribute significantly to the market growth. These fields require in-depth cellular analysis, and flow cytometry is a key tool to meet these needs. In addition, the growing interest in personalized medicine, which requires precise information at the cellular level to develop individualized treatment strategies, is another driving factor. Moreover, the rise of single-cell analysis in genomics and proteomics is boosting the demand for cell-based flow cytometry, given its capability to analyze individual cells within a population.

Breakup by Application:

Oncology

Drug Discovery

Disease Diagnosis

Stem Cell Therapy

Organ Transplantation

Hematology

Others

Oncology dominates the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes oncology, drug discovery, disease diagnosis, stem cell therapy, organ transplantation, hematology, and others. According to the report, oncology represented the largest segment.

The market in the field of oncology is largely driven by the rising global incidence of cancer and the indispensable role of this method in cancer research and patient management. Flow cytometry provides rapid, detailed analysis of cell populations, making it essential for diagnosing various forms of cancer, particularly hematological malignancies. It is also widely used for monitoring disease progression and response to treatment, thereby contributing to the decision-making process in cancer management. In confluence with this, the esclating adoption of personalized medicine in oncology, which requires high-resolution cellular analysis to develop tailored treatment strategies, further propels the demand for flow cytometry. Additionally, advancements in flow cytometry technology, such as the development of multicolor flow cytometry, have significantly enhanced its capabilities in cancer research.

Breakup by End-User:

Hospitals and Clinics

Academic and Research Institutes

Pharmaceutical and Biotechnology Companies

Others

Hospitals and clinics dominate the market

A detailed breakup and analysis of the market based on the end-user have also been provided in the report. This includes hospitals and clinics, academic and research institutes, pharmaceutical and biotechnology companies, and others. According to the report, cell-based hospitals and clinics represented the largest segment.

The market within hospitals and clinics is being driven by the growing prevalence of diseases that require flow cytometry for diagnosis and monitoring, such as cancers and immunological disorders. As the patient load for these conditions grows, so does the need for rapid, accurate diagnostic tools in these healthcare settings. Moreover, technological advancements have resulted in more compact and user-friendly flow cytometers, making it easier for hospitals and clinics to adopt this technology. The rise of personalized medicine also promotes the use of flow cytometry in these settings, as it provides the detailed cellular analysis needed for personalized treatment strategies. In addition, as this method becomes more recognized for its ability to deliver fast and comprehensive results, insurance providers are increasingly covering flow cytometry-based tests, further promoting its adoption in hospitals and clinics.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest flow cytometry market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others); Latin America (Brazil, Mexico, and Others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The growth of the flow cytometry industry in North America is driven by a well-established healthcare infrastructure and robust research environment, both of which foster the adoption and development of advanced technologies. Along with this, the high incidence of chronic diseases such as cancer, where this method plays a crucial role in diagnosis and monitoring, also contributes to market growth. Additionally, the presence of leading companies in this region supports the development of innovative technologies and applications. Furthermore, the significant investment in research and development, including biomedical research, clinical trials, and drug discovery processes that extensively use flow cytometry, further fuels market growth. The region's growing interest in personalized medicine, which requires detailed cellular analysis provided by flow cytometry, also contributes to the market demand.

Competitive Landscape:

The global flow cytometry market is experiencing significant growth due to the growing investments in research and development to create advanced flow cytometry technologies. This includes the development of new instruments, reagents, software, and methodologies. These advancements aim to enhance the capabilities of flow cytometry, making it more precise, efficient, and user-friendly. Along with this, the escalating number of strategic partnerships with other businesses, research institutions, and healthcare providers is significantly supporting the market. These collaborations often aim to advance research, develop new applications, and broaden the reach of flow cytometry technology. Apart from this, the manufacturers are introducing education and training services, such as workshops, webinars, or online tutorials to help users fully utilize the potential of flow cytometry in their work. Therefore, it is significantly supporting the market. Moreover, key players are providing strong customer service and technical support, which is creating a positive market outlook.

The report has provided a comprehensive analysis of the competitive landscape in the global flow cytometry market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Agilent Technologies Inc.

Apogee Flow Systems Ltd.

BD (Becton, Dickinson and Company)

Beckman Coulter Inc. (Danaher Corporation)

Bio-RAD Laboratories Inc.

Enzo Life Sciences Inc.

Luminex Corporation

Merck KGaA

Sony Biotechnology Inc.

Sysmex Partec GmbH

Thermo Fisher Scientific Inc.

Recent Developments:

In February 2023, Agilent Technologies Inc. announced the availability of new NovoExpress software, which brings integrated compliance tools for NovoCyte flow cytometer devices.

In June 2023, BD (Becton, Dickinson and Company) announced the global commercial launch of a new automated device that cleans samples for clinical diagnostics using flow cytometry, offering a full "walkaway" workflow solution intended to increase standardisation and repeatability in cellular diagnostics.

In June 2021, Bio-RAD Laboratories Inc. released three StarBright Dyes made for use in flow cytometry. StarBright Violet 570, 670, and 710 Dyes are appropriate for use in multicolor flow cytometry panels because to their enhanced brightness and accurate excitation and emission spectra.

Key Questions Answered in This Report

  • 1. What was the size of the global flow cytometry market in 2022?
  • 2. What is the expected growth rate of the global flow cytometry market during 2023-2028?
  • 3. What are the key factors driving the global flow cytometry market?
  • 4. What has been the impact of COVID-19 on the global flow cytometry market?
  • 5. What is the breakup of the global flow cytometry market based on the product and service?
  • 6. What is the breakup of the global flow cytometry market based on the technology?
  • 7. What is the breakup of the global flow cytometry market based on the application?
  • 8. What is the breakup of the global flow cytometry market based on the end-user?
  • 9. What are the key regions in the global flow cytometry market?
  • 10. Who are the key players/companies in the global flow cytometry market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Flow Cytometry Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product and Service

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents and Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Accessories
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Software
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Services
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Cell-Based Flow Cytometry
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bead-Based Flow Cytometry
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Drug Discovery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Disease Diagnosis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Stem Cell Therapy
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Organ Transplantation
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Hematology
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic and Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Apogee Flow Systems Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 BD (Becton, Dickinson and Company)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Bio-RAD Laboratories Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Enzo Life Sciences Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Luminex Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sony Biotechnology Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Sysmex Partec GmbH
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Flow Cytometry Market: Major Drivers and Challenges
  • Figure 2: Global: Flow Cytometry Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Flow Cytometry Market: Breakup by Product and Service (in %), 2022
  • Figure 4: Global: Flow Cytometry Market: Breakup by Technology (in %), 2022
  • Figure 5: Global: Flow Cytometry Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Flow Cytometry Market: Breakup by End-User (in %), 2022
  • Figure 7: Global: Flow Cytometry Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Flow Cytometry Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 9: Global: Flow Cytometry (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Flow Cytometry (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Flow Cytometry (Reagents and Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Flow Cytometry (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Flow Cytometry (Accessories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Flow Cytometry (Accessories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Flow Cytometry (Software) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Flow Cytometry (Software) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Flow Cytometry (Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Flow Cytometry (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Flow Cytometry (Cell-Based) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Flow Cytometry (Cell-Based) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Flow Cytometry (Bead-Based) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Flow Cytometry (Bead-Based) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Flow Cytometry (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Flow Cytometry (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Flow Cytometry (Drug Discovery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Flow Cytometry (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Flow Cytometry (Disease Diagnosis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Flow Cytometry (Disease Diagnosis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Flow Cytometry (Stem Cell Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Flow Cytometry (Stem Cell Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Flow Cytometry (Organ Transplantation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Flow Cytometry (Organ Transplantation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Flow Cytometry (Hematology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Flow Cytometry (Hematology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Flow Cytometry (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Flow Cytometry (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Flow Cytometry (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Flow Cytometry (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Flow Cytometry (Academic and Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Flow Cytometry (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Flow Cytometry (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Flow Cytometry (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Global: Flow Cytometry (Other End-Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Global: Flow Cytometry (Other End-Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: North America: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: North America: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: United States: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: United States: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Canada: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Canada: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Asia Pacific: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Asia Pacific: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: China: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: China: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Japan: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Japan: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: India: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: India: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: South Korea: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: South Korea: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Australia: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Australia: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Indonesia: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Indonesia: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Others: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Others: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Europe: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Europe: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Germany: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Germany: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: France: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: France: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: United Kingdom: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: United Kingdom: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Italy: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Italy: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Spain: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Spain: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Russia: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Russia: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Others: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Others: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Latin America: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Latin America: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Brazil: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Brazil: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Mexico: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Mexico: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Others: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Others: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 91: Middle East and Africa: Flow Cytometry Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 92: Middle East and Africa: Flow Cytometry Market: Breakup by Country (in %), 2022
  • Figure 93: Middle East and Africa: Flow Cytometry Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 94: Global: Flow Cytometry Industry: SWOT Analysis
  • Figure 95: Global: Flow Cytometry Industry: Value Chain Analysis
  • Figure 96: Global: Flow Cytometry Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Flow Cytometry Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Flow Cytometry Market Forecast: Breakup by Product and Service (in Million US$), 2023-2028
  • Table 3: Global: Flow Cytometry Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 4: Global: Flow Cytometry Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Flow Cytometry Market Forecast: Breakup by End-User (in Million US$), 2023-2028
  • Table 6: Global: Flow Cytometry Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Flow Cytometry Market: Competitive Structure
  • Table 8: Global: Flow Cytometry Market: Key Players